Key result
A 37-year-old female developed early-onset severe bilateral mitral and tricuspid regurgitation 6 years after receiving mediastinal radiotherapy and chemotherapy for Hodgkin lymphoma.
Why the study?
Radiation-induced valvulopathy is a common complication of mediastinal radiotherapy that typically manifests at least 10 years post-exposure, prompting consideration of whether screening is warranted earlier.
Case Report (n=1)
No
Radiation-induced valvulopathy can occur earlier than the typically expected 10-year timeframe, suggesting that screening intervals may need to be individualized based on radiation dose and concomitant anthracycline use.
Answers are grounded in this paper and cite their sources.
May warrant earlier RIV consideration in symptomatic survivors; leaves open optimal screening timelines.
Background: Radiation-induced valvulopathy (RIV) is a common complication of mediastinal radiotherapy and usually occurs at least 10 years after exposure to radiotherapy. Case Report: We report the case of a 37-year-old female with a history of stage IIIB Hodgkin lymphoma who was diagnosed with RIV after all other potential causes of shortness of breath and valvular dysfunction were excluded. The patient9s presentation, 6 years after receiving chemotherapy and radiotherapy for Hodgkin lymphoma, was earlier than expected after mediastinal radiotherapy. The patient was started on a regimen of lisinopril, nifedipine, and metoprolol, and her symptoms improved significantly within 4 days of starting medical therapy. We review the literature, discuss the risk factors and determinants of developing RIV, and suggest the ideal timing to screen patients. Conclusion: This case is of educational value for internal medicine, oncology, and cardiology healthcare providers who should consider RIV as a cause of shortness of breath in patients who underwent mediastinal radiotherapy for Hodgkin lymphoma.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2019) conducted a case report in Radiation-induced valvulopathy (n=1). Mediastinal radiotherapy and chemotherapy was evaluated on Development of severe mitral and tricuspid regurgitation. A 37-year-old female developed early-onset severe bilateral mitral and tricuspid regurgitation 6 years after receiving mediastinal radiotherapy and chemotherapy for Hodgkin lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: